{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:42:08Z","timestamp":1791420128339,"version":"4.3.3"},"reference-count":43,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2012,5,9]],"date-time":"2012-05-09T00:00:00Z","timestamp":1336521600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0036438","type":"journal-article","created":{"date-parts":[[2012,5,9]],"date-time":"2012-05-09T20:58:35Z","timestamp":1336597115000},"page":"e36438","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":52,"title":["International Network for Comparison of HIV Neutralization Assays: The NeutNet Report II"],"prefix":"10.1371","volume":"7","author":[{"given":"Leo","family":"Heyndrickx","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Heath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enas","family":"Sheik-Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Alcami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Bongertz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Jansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Malnati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Montefiori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Moog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saladin","family":"Osmanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Polonis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghna","family":"Ramaswamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quentin","family":"Sattentau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Tolazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanneke","family":"Schuitemaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betty","family":"Willems","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terri","family":"Wrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva Maria","family":"Feny\u00f6","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Scarlatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,5,9]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1001\/jama.1994.03520060075035","article-title":"Neutralizing antibodies to HIV-1 in seronegative volunteers immunized with recombinant gp120 from the MN strain of HIV-1. NIAID AIDS Vaccine Clinical Trials Network.","volume":"272","author":"RB Belshe","year":"1994","journal-title":"JAMA : the journal of the American Medical Association"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"183","DOI":"10.2174\/1566524033479825","article-title":"HIV vaccines: a global perspective.","volume":"3","author":"J Esparza","year":"2003","journal-title":"Current molecular medicine"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"4478","DOI":"10.1073\/pnas.85.12.4478","article-title":"Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees.","volume":"85","author":"J Goudsmit","year":"1988","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1089\/08892220050042846","article-title":"A phase II study of two HIV type 1 envelope vaccines, comparing their immunogenicity in populations at risk for acquiring HIV type 1 infection. AIDS Vaccine Evaluation Group.","volume":"16","author":"MJ McElrath","year":"2000","journal-title":"AIDS research and human retroviruses"},{"key":"ref5","first-page":"S97","article-title":"The role of the humoral immune response in HIV infection.","author":"EM Fenyo","year":"1996"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1089\/aid.1994.10.1325","article-title":"The World Health Organization Network for HIV Isolation and Characterization: summary of a pilot study.","volume":"10","author":"S Osmanov","year":"1994","journal-title":"AIDS research and human retroviruses"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0140-6736(03)12669-4","article-title":"HIV vaccine fails in phase 3 trial.","volume":"361","author":"M McCarthy","year":"2003","journal-title":"Lancet"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/449390c","article-title":"HIV vaccine failure prompts Merck to halt trial.","volume":"449","year":"2007","journal-title":"Nature"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nri2674","article-title":"The immune response during acute HIV-1 infection: clues for vaccine development.","volume":"10","author":"AJ McMichael","year":"2010","journal-title":"Nature reviews Immunology"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1128\/JVI.70.1.427-444.1996","article-title":"Inter- and intraclade neutralization of human immunodeficiency virus type 1: genetic clades do not correspond to neutralization serotypes but partially correspond to gp120 antigenic serotypes.","volume":"70","author":"JP Moore","year":"1996","journal-title":"Journal of virology"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"6235","DOI":"10.1128\/JVI.70.9.6235-6243.1996","article-title":"Multivariate analysis of human immunodeficiency virus type 1 neutralization data.","volume":"70","author":"PN Nyambi","year":"1996","journal-title":"Journal of virology"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"7827","DOI":"10.1128\/JVI.70.11.7827-7832.1996","article-title":"Neutralization serotypes of human immunodeficiency virus type 1 field isolates are not predicted by genetic subtype. The WHO Network for HIV Isolation and Characterization.","volume":"70","author":"J Weber","year":"1996","journal-title":"Journal of virology"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1097\/00002030-199109000-00001","article-title":"Evaluation of monoclonal antibodies to HIV-1 by neutralization and serological assays: an international collaboration. Collaborating Investigators.","volume":"5","author":"MP D\u2019Souza","year":"1991","journal-title":"AIDS"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1086\/516443","article-title":"Evaluation of monoclonal antibodies to human immunodeficiency virus type 1 primary isolates by neutralization assays: performance criteria for selecting candidate antibodies for clinical trials. AIDS Clinical Trials Group Antibody Selection Working Group.","volume":"175","author":"MP D\u2019Souza","year":"1997","journal-title":"The Journal of infectious diseases"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"10108","DOI":"10.1128\/JVI.79.16.10108-10125.2005","article-title":"Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies.","volume":"79","author":"M Li","year":"2005","journal-title":"Journal of virology"},{"key":"ref16","article-title":"Development and implementation of an international proficiency testing program for a neutralizing antibody assay for HIV-1 in TZM-bl cells.","author":"CA Todd","year":"2011"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"e4505","DOI":"10.1371\/journal.pone.0004505","article-title":"International network for comparison of HIV neutralization assays: the NeutNet report.","volume":"4","author":"EM Fenyo","year":"2009","journal-title":"PloS one"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/jmv.10490","article-title":"Epitopes corresponding to the envelope genetic subtype are present on the surface of free virions of HIV-1 group M primary isolates and can be detected in neutralization assays with extended incubation phases.","volume":"71","author":"D Davis","year":"2003","journal-title":"Journal of medical virology"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"8533","DOI":"10.1128\/JVI.02816-06","article-title":"Susceptibility of recently transmitted subtype B human immunodeficiency virus type 1 variants to broadly neutralizing antibodies.","volume":"81","author":"ED Quakkelaar","year":"2007","journal-title":"Journal of virology"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/infdis\/168.1.207","article-title":"Mother-to-child transmission of human immunodeficiency virus type 1: correlation with neutralizing antibodies against primary isolates.","volume":"168","author":"G Scarlatti","year":"1993","journal-title":"The Journal of infectious diseases"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1128\/JVI.02625-05","article-title":"Nonneutralizing antibodies are able to inhibit human immunodeficiency virus type 1 replication in macrophages and immature dendritic cells.","volume":"80","author":"V Holl","year":"2006","journal-title":"Journal of virology"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1089\/088922201750056807","article-title":"HIV type 1 subtype E-infected patients with broadened, dual (B\/E) V3 loop serology have increased cross-neutralizing antibodies.","volume":"17","author":"VR Polonis","year":"2001","journal-title":"AIDS research and human retroviruses"},{"key":"ref23","first-page":"273","article-title":"Plaque-reduction assays for human and simian immunodeficiency virus neutralization.","volume":"304","author":"A Nordqvist","year":"2005","journal-title":"Methods in molecular biology"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1089\/088922202760265623","article-title":"A new cell line-based neutralization assay for primary HIV type 1 isolates.","volume":"18","author":"Y Shi","year":"2002","journal-title":"AIDS research and human retroviruses"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1128\/JVI.73.3.2343-2349.1999","article-title":"Primary human immunodeficiency virus type 2 (HIV-2) isolates, like HIV-1 isolates, frequently use CCR5 but show promiscuity in coreceptor usage.","volume":"73","author":"A Morner","year":"1999","journal-title":"Journal of virology"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0092-8674(86)90590-8","article-title":"The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain.","volume":"47","author":"PJ Maddon","year":"1986","journal-title":"Cell"},{"key":"ref27","doi-asserted-by":"crossref","DOI":"10.1002\/0471142735.im1211s64","article-title":"Evaluating neutralizing antibodies against HIV, SIV, and SHIV in luciferase reporter gene assays.","volume":"11","author":"DC Montefiori","year":"2005","journal-title":"Curr Protoc Immunol Chapter 12: Unit 12"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"4144","DOI":"10.1073\/pnas.0630530100","article-title":"Rapid evolution of the neutralizing antibody response to HIV type 1 infection.","volume":"100","author":"DD Richman","year":"2003","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jviromet.2007.11.009","article-title":"Antiviral compounds show enhanced activity in HIV-1 single cycle pseudovirus assays as compared to classical PBMC assays.","volume":"148","author":"L Heyndrickx","year":"2008","journal-title":"J Virol Methods"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1468-1293.2007.00540.x","article-title":"A new strategy based on recombinant viruses for assessing the replication capacity of HIV-1.","volume":"9","author":"J Garcia-Perez","year":"2008","journal-title":"HIV medicine"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1093\/jac\/dkq379","article-title":"A sensitive phenotypic assay for the determination of human immunodeficiency virus type 1 tropism.","volume":"65","author":"N Gonzalez","year":"2010","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"R100","DOI":"10.1186\/gb-2006-7-10-r100","article-title":"CellProfiler: image analysis software for identifying and quantifying cell phenotypes.","volume":"7","author":"AE Carpenter","year":"2006","journal-title":"Genome biology"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"6988","DOI":"10.1128\/JVI.72.9.6988-6996.1998","article-title":"Neutralization profiles of primary human immunodeficiency virus type 1 isolates in the context of coreceptor usage.","volume":"72","author":"D Cecilia","year":"1998","journal-title":"Journal of virology"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1099\/vir.0.81409-0","article-title":"Comparative studies on mucosal and intravenous transmission of simian immunodeficiency virus (SIVsm): the kinetics of evolution to neutralization resistance are related to progression rate of disease.","volume":"87","author":"A Lauren","year":"2006","journal-title":"The Journal of general virology"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"e1001084","DOI":"10.1371\/journal.ppat.1001084","article-title":"Generation of neutralizing antibodies and divergence of SIVmac239 in cynomolgus macaques following short-term early antiretroviral therapy.","volume":"6","author":"G Ozkaya Sahin","year":"2010","journal-title":"PLoS pathogens"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1128\/JVI.06315-11","article-title":"Potent intratype neutralizing activity distinguishes human immunodeficiency virus type 2 (HIV-2) from HIV-1.","volume":"86","author":"G Ozkaya Sahin","year":"2012","journal-title":"Journal of virology"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"e1001028","DOI":"10.1371\/journal.ppat.1001028","article-title":"A limited number of antibody specificities mediate broad and potent serum neutralization in selected HIV-1 infected individuals.","volume":"6","author":"LM Walker","year":"2010","journal-title":"PLoS pathogens"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1128\/JVI.01992-08","article-title":"Analysis of neutralization specificities in polyclonal sera derived from human immunodeficiency virus type 1-infected individuals.","volume":"83","author":"Y Li","year":"2009","journal-title":"Journal of virology"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"8925","DOI":"10.1128\/JVI.00758-09","article-title":"Antibody specificities associated with neutralization breadth in plasma from human immunodeficiency virus type 1 subtype C-infected blood donors.","volume":"83","author":"ES Gray","year":"2009","journal-title":"J Virol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.virol.2008.02.007","article-title":"Recent advances in the characterization of HIV-1 neutralization assays for standardized evaluation of the antibody response to infection and vaccination.","volume":"375","author":"VR Polonis","year":"2008","journal-title":"Virology"},{"key":"ref41","first-page":"8","article-title":"Antibodies: beyond neutralization.","volume":"14","author":"A von Bubnoff","year":"2010","journal-title":"IAVI report : newsletter on international AIDS vaccine research"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/COH.0b013e32832f0a89","article-title":"Fc receptor-mediated antiviral antibodies.","volume":"4","author":"DN Forthal","year":"2009","journal-title":"Current opinion in HIV and AIDS"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.4049\/jimmunol.139.7.2263","article-title":"Antibody-dependent cellular cytotoxicity-inducing antibodies against human immunodeficiency virus. Presence at different clinical stages.","volume":"139","author":"K Ljunggren","year":"1987","journal-title":"Journal of immunology"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0036438","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,22]],"date-time":"2023-06-22T16:05:32Z","timestamp":1687449932000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0036438"}},"subtitle":[],"editor":[{"given":"Shibo","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,5,9]]},"references-count":43,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2012,5,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0036438","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,9]]}}}